| Monocyte | [PC] Peripheral blood monocyte | SPI1 / PU.1 | GSE31621 | GSM785495 | N/A |
| Macrophage | [PC] Peripheral blood derived macrophage | SPI1 / PU.1 | GSE31621 | GSM785501 | Macrophages were derived from peripheral blood mon... |
| Macrophage | [PC] Peripheral blood derived macrophage | CEBPB | GSE31621 | GSM785502 | Macrophages were derived from peripheral blood mon... |
| Macrophage | [PC] Peripheral blood derived macrophage | EGR2 | GSE31621 | GSM785503 - GSM785504 | Macrophages were derived from peripheral blood mon... |
| Umbilical cord blood | [PC] CD133+ hematopoietic stem and progenitor cells | SPI1 / PU.1 | GSE26014 | GSM638310 - GSM638311 | UCB cells were expanded in vitro for 10-11 days, f... |
| Umbilical cord blood | [PC] CD133+ hematopoietic stem and progenitor cells | IKZF1 / IKAROS | GSE26014 | GSM638312 - GSM638313 | UCB cells were expanded in vitro for 10-11 days, f... |
| Umbilical cord blood | [PC] CD133+ hematopoietic stem and progenitor cells | MEIS1 | GSE26014 | GSM638314 - GSM638315 - GSM638316 | UCB cells were expanded in vitro for 10-11 days, f... |
| Erythroblast | [PC] Adult peripheral blood derived proerythroblast | SMAD1 | GSE29194 | GSM722397 | Proerythroblasts were derived from CD34+ cells mob... |
| Erythroblast | [PC] Adult peripheral blood derived proerythroblast | SMAD1 | GSE29194 | GSM722398 | Proerythroblasts were derived from CD34+ cells mob... |
| Haematopoietic stem and progenitor cells | [PC] CD34+ hematopoietic stem and progenitor cells | SMAD1 | GSE29194 | GSM722400 | mobilised CD34+ cells were expanded for 6 days bef... |
| Haematopoietic stem and progenitor cells | [PC] CD34+ hematopoietic stem and progenitor cells | TCF7L2 | GSE29194 | GSM722401 | mobilised CD34+ cells were expanded for 6 days bef... |
| Haematopoietic stem and progenitor cells | [PC] CD34+ hematopoietic stem and progenitor cells | TCF7L2 | GSE29194 | GSM722402 | mobilised CD34+ cells were expanded for 6 days bef... |
| Megakaryocyte | [PC] CD34+ UCB derived MKs | GATA1 | GSE24674 | GSM607949 | CD34+ UCB cells differentiated into MKs for 10 day... |
| Megakaryocyte | [PC] CD34+ UCB derived MKs | GATA2 | GSE24674 | GSM607950 | CD34+ UCB cells differentiated into MKs for 10 day... |
| Megakaryocyte | [PC] CD34+ UCB derived MKs | RUNX1 | GSE24674 | GSM607951 | CD34+ UCB cells differentiated into MKs for 10 day... |
| Megakaryocyte | [PC] CD34+ UCB derived MKs | FLI1 | GSE24674 | GSM607952 | CD34+ UCB cells differentiated into MKs for 10 day... |
| Megakaryocyte | [PC] CD34+ UCB derived MKs | TAL1 | GSE24674 | GSM607953 | CD34+ UCB cells differentiated into MKs for 10 day... |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] Jurkat | TAL1 | GSE25000 | GSM614003 | N/A |
| Erythroblast | [PC] Adult peripheral blood derived proerythroblast | TAL1 | GSE25000 | GSM614004 | Proerythroblasts were derived from CD34+ cells mob... |
| Haematopoietic stem and progenitor cells | [PC] CD34+ hematopoietic stem and progenitor cells | ERG | GSE45144 | GSM1097879 | N/A |
| Haematopoietic stem and progenitor cells | [PC] CD34+ hematopoietic stem and progenitor cells | FLI1 | GSE45144 | GSM1097880 | N/A |
| Haematopoietic stem and progenitor cells | [PC] CD34+ hematopoietic stem and progenitor cells | TAL1 / SCL | GSE45144 | GSM1097881 | N/A |
| Haematopoietic stem and progenitor cells | [PC] CD34+ hematopoietic stem and progenitor cells | LYL1 | GSE45144 | GSM1097882 | N/A |
| Haematopoietic stem and progenitor cells | [PC] CD34+ hematopoietic stem and progenitor cells | GATA2 | GSE45144 | GSM1097883 | N/A |
| Haematopoietic stem and progenitor cells | [PC] CD34+ hematopoietic stem and progenitor cells | RUNX1 | GSE45144 | GSM1097884 | N/A |
| Haematopoietic stem and progenitor cells | [PC] CD34+ hematopoietic stem and progenitor cells | LMO2 | GSE45144 | GSM1097885 | N/A |
| Erythroblast | [PC] Fetal liver derived proerythroblast | TAL1 | GSE36985 | GSM908054 | CD34+ HSPC-derived proerythroblasts from 2-trimest... |
| Erythroblast | [PC] Adult peripheral blood derived proerythroblast | TAL1 | GSE36985 | GSM908055 | CD34+ HSPC-derived proerythroblasts in GCSF-mobili... |
| Erythroblast | [PC] Adult peripheral blood derived proerythroblast | NFE2 | GSE36985 | GSM908059 | CD34+ HSPC-derived proerythroblasts in GCSF-mobili... |
| Erythroblast | [PC] Adult peripheral blood derived proerythroblast | POLR2A | GSE36985 | GSM908069 | CD34+ HSPC-derived proerythroblasts in GCSF-mobili... |
| Erythroblast | [PC] Fetal liver derived proerythroblast | GATA1 | GSE36985 | GSM970257 | CD34+ HSPC-derived proerythroblasts from 2-trimest... |
| Erythroblast | [PC] Adult peripheral blood derived proerythroblast | GATA1 | GSE36985 | GSM970258 | CD34+ HSPC-derived proerythroblasts in GCSF-mobili... |
| Erythroblast | [PC] Fetal liver derived proerythroblast | POLR2A | GSE36985 | GSM970259 | CD34+ HSPC-derived proerythroblasts from 2-trimest... |
| Erythroblast | [PC] Adult peripheral blood derived proerythroblast | POLR2A | GSE36985 | GSM970260 | CD34+ HSPC-derived proerythroblasts in GCSF-mobili... |
| Erythroblast | [PC] Adult peripheral blood derived proerythroblast | IRF2 | GSE36985 | GSM970261 | CD34+ HSPC-derived proerythroblasts in GCSF-mobili... |
| Haematopoietic stem and progenitor cells | [PC] CD34+ hematopoietic stem and progenitor cells | CTCF | GSE26501 | GSM651541 | N/A |
| Erythroid Progenitor | [PC] CD36+ erythroid progenitor | CTCF | GSE26501 | GSM651542 | HSCs differentiated into CD36+ erythroid lineage, ... |
| Erythroid Progenitor | [PC] CD36+ erythroid progenitor | CTCF | GSE26501 | GSM651543 | HSCs differentiated into CD36+ erythroid lineage, ... |
| Erythroid Progenitor | [PC] CD36+ erythroid progenitor | TAL1 | GSE26501 | GSM651544 | HSCs differentiated into CD36+ erythroid lineage, ... |
| Erythroid Progenitor | [PC] CD36+ erythroid progenitor | TAL1 | GSE26501 | GSM651545 | HSCs differentiated into CD36+ erythroid lineage, ... |
| Erythroid Progenitor | [PC] CD36+ erythroid progenitor | GATA1 | GSE26501 | GSM651546 | HSCs differentiated into CD36+ erythroid lineage, ... |
| Erythroid Progenitor | [PC] CD36+ erythroid progenitor | GATA1 | GSE26501 | GSM651547 | HSCs differentiated into CD36+ erythroid lineage, ... |
| Haematopoietic stem and progenitor cells | [PC] CD34+ hematopoietic stem and progenitor cells | BRG1 / SMARCA4 | GSE26501 | GSM651552 | N/A |
| Erythroid Progenitor | [PC] CD36+ erythroid progenitor | BRG1/SMARCA4 | GSE26501 | GSM651553 | WT |
| Pro-B acute lymphoblastic leukemia (B-ALL) | [CL] RS4;11 | KMT2A / MLL | GSE34941 | GSM941543 | t(4;11) and MLL/A4 fusion protein; note RC Stong e... |
| Pro-B acute lymphoblastic leukemia (B-ALL) | [CL] RS4;11 | AFF1 / AF4 | GSE34941 | GSM941544 | t(4;11) and MLL/A4 fusion protein; note RC Stong e... |
| Acute promyelocytic leukemia (APML) | [CL] NB4 | EP300 | GSE30254 | GSM749524 | AML FAB M3 and t(15;17) |
| Acute myeloid leukemia (AML) | [CL] SKNO-1 | EP300 | GSE30254 | GSM835863 | AML FAB M2 and t(8;21) and monosomy 17 and AML1/MT... |
| Acute myelomonocytic leukemia (AML) | [CL] ME-1 | CBFB | GSE46044 | GSM1122302 | AML FAB M4Eo and inv(16) and CBFB-MYH11 |
| Acute myelomonocytic leukemia (AML) | [CL] ME-1 | CBFB | GSE46044 | GSM1122303 | AML FAB M4Eo and inv(16) and CBFB-MYH11 |
| Acute myelomonocytic leukemia (AML) | [CL] ME-1 | MYH11 | GSE46044 | GSM1122304 | AML FAB M4Eo and inv(16) and CBFB-MYH11 |
| AML FAB M4Eo and inv(16) and CBFB-MYH11 | [CL] ME-1 | MYH11 | GSE46044 | GSM1122305 | AML FAB M4Eo and inv(16) and CBFB-MYH11 |
| Acute myelomonocytic leukemia (AML) | [CL] ME-1 | RUNX1 | GSE46044 | GSM1122306 | AML FAB M4Eo and inv(16) and CBFB-MYH11 |
| Acute myelomonocytic leukemia (AML) | [CL] ME-1 | MED21 | GSE46044 | GSM1122307 | AML FAB M4Eo and inv(16) and CBFB-MYH11 |
| Acute myelomonocytic leukemia (AML) | [CL] ME-1 | TBP | GSE46044 | GSM1122308 | AML FAB M4Eo and inv(16) and CBFB-MYH11 |
| Acute myelomonocytic leukemia (AML) | [CL] ME-1 | TCF12 / HEB | GSE46044 | GSM1122309 | AML FAB M4Eo and inv(16) and CBFB-MYH11 |
| Acute myelomonocytic leukemia (AML) | [CL] ME-1 | GATA2 | GSE46044 | GSM1122310 | AML FAB M4Eo and inv(16) and CBFB-MYH11 |
| Acute myelomonocytic leukemia (AML) | [CL] ME-1 | TAL1 | GSE46044 | GSM1122311 | AML FAB M4Eo and inv(16) and CBFB-MYH11 |
| Acute myelomonocytic leukemia (AML) | [CL] ME-1 | FLI1 | GSE46044 | GSM1122312 | AML FAB M4Eo and inv(16) and CBFB-MYH11 |
| Acute myelomonocytic leukemia (AML) | [CL] ME-1 | ELF1 | GSE46044 | GSM1122313 | AML FAB M4Eo and inv(16) and CBFB-MYH11 |
| Acute myelomonocytic leukemia (AML) | [CL] ME-1 | ERG | GSE46044 | GSM1122314 | AML FAB M4Eo and inv(16) and CBFB-MYH11 |
| Acute myelomonocytic leukemia (AML) | [CL] ME-1 | SPI1 / PU.1 | GSE46044 | GSM1122315 | AML FAB M4Eo and inv(16) and CBFB-MYH11 |
| Acute myelomonocytic leukemia (AML) | [CL] ME-1 | EP300 | GSE46044 | GSM1122317 | AML FAB M4Eo and inv(16) and CBFB-MYH11 |
| Acute myelomonocytic leukemia (AML) | [CL] ME-1 | HDAC1 | GSE46044 | GSM1122318 | AML FAB M4Eo and inv(16) and CBFB-MYH11 |
| Acute myeloid leukemia (AML) | [PC] CD34+ acute myeloid leukemia blast cells | MYH11 | GSE46044 | GSM1122319 | inv(16) and CBFB-MYH11 |
| Acute myeloid leukemia (AML) | [PC] CD34+ acute myeloid leukemia blast cells | CBFB | GSE46044 | GSM1122320 | inv(16) and CBFB-MYH11 |
| Immortalised monocyte progenitor | [CL] U937 | CBFB | GSE46044 | GSM1122321 | U937 with conditional expression of CBFB-MYH11 by ... |
| Immortalised monocyte progenitor | [CL] U937 | CBFB | GSE46044 | GSM1122322 | U937 with conditional expression of CBFB-MYH11 by ... |
| Immortalised monocyte progenitor | [CL] U937 | MYH11 | GSE46044 | GSM1122323 | U937 with conditional expression of CBFB-MYH11 by ... |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 | RUNX1T1 / ETO | GSE43834 | GSM1082306 | AML M2 and t(8;21) and AML1-ETO / RUNX1-CBF2T1 fus... |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 | TCF12 / HEB | GSE43834 | GSM1082308 | AML M2 and t(8;21) and AML1-ETO / RUNX1-CBF2T1 fus... |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 | TCF3 / E2A | GSE43834 | GSM1082309 | AML M2 and t(8;21) and AML1-ETO / RUNX1-CBF2T1 fus... |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 | LMO2 | GSE43834 | GSM1082311 | AML M2 and t(8;21) and AML1-ETO / RUNX1-CBF2T1 fus... |
| Acute megakaryocytic leukemia (AML) | [CL] CMK | RUNX1 | GSE24779 | GSM610330 | AML FAB M7 and Trisomy 21 |
| Erythrocytic leukemia cells | [CL] K562 | RUNX1 | GSE24779 | GSM610332 | erythrocytic leukemia cells from patient with CML ... |
| Erythrocytic leukemia cells | [CL] K562 | RUNX1 | GSE24779 | GSM610334 | erythrocytic leukemia cells from patient with CML ... |
| Erythrocytic leukemia cells | [CL] K562 | GATA1 | GSE24779 | GSM610335 | erythrocytic leukemia cells from patient with CML ... |
| Erythrocytic leukemia cells | [CL] K562 | FOS | GSE24779 | GSM610336 | erythrocytic leukemia cells from patient with CML ... |
| Erythrocytic leukemia cells | [CL] K562 | FOS | GSE24779 | GSM610337 | erythrocytic leukemia cells from patient with CML ... |
| Diffuse large B cell lymphoma (DLBCL) | [CL] OCI-Ly7 | MAFK | GSE47784 | GSM1159670 | DLBCL and t(8;14) and MYC-IGH fusion and P53 mutat... |
| Diffuse large B cell lymphoma (DLBCL) | [CL] OCI-Ly7 | BACH2 | GSE44420 | GSM1084800 | DLBCL and t(8;14) and MYC-IGH fusion and P53 mutat... |
| Diffuse large B cell lymphoma (DLBCL) | [CL] OCI-Ly7 | BCL6 | GSE44420 | GSM1084801 | DLBCL and t(8;14) and MYC-IGH fusion and P53 mutat... |
| Erythroblast | [PC] Bone marrow derived proerythroblast | GATA1 | GSE52924 | GSM1278240 | CD34+ HSPC-derived proerythroblasts in GCSF-mobili... |
| Erythroblast | [PC] Bone marrow derived proerythroblast | TAL1 | GSE52924 | GSM1278241 | CD34+ HSPC-derived proerythroblasts in GCSF-mobili... |
| Erythroblast | [PC] Bone marrow derived proerythroblast | GFI1B | GSE52924 | GSM1278242 | CD34+ HSPC-derived proerythroblasts in GCSF-mobili... |
| T-cell Lymphoblastic Lymphoma | [CL] CUTLL1 | ETS1 | GSE51800 | GSM1252929 | t(7;9) translocation and TCRB-NOTCH1 fusion |
| T-cell Lymphoblastic Lymphoma | [CL] CUTLL1 | GABPA | GSE51800 | GSM1252930 | t(7;9) translocation and TCRB-NOTCH1 fusion |
| T-cell Lymphoblastic Lymphoma | [CL] CUTLL1 | RUNX1 | GSE51800 | GSM1252931 | t(7;9) translocation and TCRB-NOTCH1 fusion |
| T-cell Lymphoblastic Lymphoma | [CL] CUTLL1 | NOTCH1 | GSE51800 | GSM1252933 | t(7;9) translocation and TCRB-NOTCH1 fusion; treat... |
| T-cell Lymphoblastic Lymphoma | [CL] CUTLL1 | RBPJ | GSE51800 | GSM1252934 | t(7;9) translocation and TCRB-NOTCH1 fusion; treat... |
| T-cell Lymphoblastic Lymphoma | [CL] CUTLL1 | NOTCH1 | GSE51800 | GSM1252936 | t(7;9) translocation and TCRB-NOTCH1 fusion; treat... |
| T-cell Lymphoblastic Lymphoma | [CL] CUTLL1 | RBPJ | GSE51800 | GSM1252937 | t(7;9) translocation and TCRB-NOTCH1 fusion; treat... |
| T-cell Lymphoblastic Lymphoma | [CL] CUTLL1 | BRD4 | GSE51800 | GSM1252941 | t(7;9) translocation and TCRB-NOTCH1 fusion |
| T-cell Lymphoblastic Lymphoma | [CL] CUTLL1 | MED1 | GSE51800 | GSM1252942 | t(7;9) translocation and TCRB-NOTCH1 fusion |
| T-cell Lymphoblastic Lymphoma | [CL] CUTLL1 | EP300 | GSE51800 | GSM1252943 | t(7;9) translocation and TCRB-NOTCH1 fusion |
| Erythrocytic leukemia cells | [CL] K562 | GATA1 | GSE18868 | GSM467647 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Erythrocytic leukemia cells | [CL] K562 | GATA2 | GSE18868 | GSM467648 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Erythrocytic leukemia cells | [CL] K562 | CBX2 | GSE32509 | GSM830986 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Erythrocytic leukemia cells | [CL] K562 | CBX8 | GSE32509 | GSM830987 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Erythrocytic leukemia cells | [CL] K562 | KDM5C/JARID1C | GSE32509 | GSM831000 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Erythrocytic leukemia cells | [CL] K562 | CREBBP/KAT3A | GSE32509 | GSM831001 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Erythrocytic leukemia cells | [CL] K562 | KDM1A/LSD1 | GSE32509 | GSM831002 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Erythrocytic leukemia cells | [CL] K562 | NCOR1 | GSE32509 | GSM831004 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Erythrocytic leukemia cells | [CL] K562 | WHSC1 | GSE32509 | GSM831005 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Erythrocytic leukemia cells | [CL] K562 | EP300 | GSE32509 | GSM831006 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Erythrocytic leukemia cells | [CL] K562 | PHF8 | GSE32509 | GSM831008 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Erythrocytic leukemia cells | [CL] K562 | PHF8 | GSE32509 | GSM831009 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Erythrocytic leukemia cells | [CL] K562 | KDM5B/PLU1/JARID1B | GSE32509 | GSM831010 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Erythrocytic leukemia cells | [CL] K562 | KDM5B/PLU1/JARID1B | GSE32509 | GSM831011 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Erythrocytic leukemia cells | [CL] K562 | REST | GSE32509 | GSM831015 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Erythrocytic leukemia cells | [CL] K562 | POLR2A | GSE32509 | GSM831016 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Erythrocytic leukemia cells | [CL] K562 | RNF2 | GSE32509 | GSM831017 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Erythrocytic leukemia cells | [CL] K562 | SIRT6 | GSE32509 | GSM831020 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Erythrocytic leukemia cells | [CL] K562 | SUZ12 | GSE32509 | GSM831021 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] Jurkat | POLR2A | GSE50625 | GSM1224784 | Jurkat T-ALL cell line treated with DMSO/vehicle f... |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] Jurkat | POLR2A | GSE50625 | GSM1224785 | Jurkat T-ALL cell line treated with THZ-2-102 for ... |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] Jurkat | POLR2A | GSE50625 | GSM1224786 | Jurkat T-ALL cell line treated with THZ-2-149 for ... |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] Jurkat | POLR2A | GSE50625 | GSM1224787 | Jurkat T-ALL cell line treated with flavopiridol f... |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] Jurkat | CDK7 | GSE50625 | GSM1296385 | Untreated Jurkat T-ALL cell line. |
| B lymphoblast multiple myeloma cells | [CL] MM1.S | CDK7 | GSE50625 | GSM1313922 | treated with DMSO for 6 hours, used with Cdk7 inhi... |
| B lymphoblast multiple myeloma cells | [CL] MM1.S | POLR2A | GSE50625 | GSM1313923 | treated with DMSO for 6 hours, used as vehicle con... |
| B lymphoblast multiple myeloma cells | [CL] MM1.S | CDK9 | GSE50625 | GSM1313924 | treated with DMSO for 6 hours, used with Cdk9 inhi... |
| Erythrocytic leukemia cells | [CL] K562 | CHD1 | GSE32509 | GSM830988 - GSM830989 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Erythrocytic leukemia cells | [CL] K562 | HDAC1 | GSE32509 | GSM830993 - GSM830994 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Erythrocytic leukemia cells | [CL] K562 | HDAC2 | GSE32509 | GSM830995 - GSM830996 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Erythrocytic leukemia cells | [CL] K562 | RBBP5 | GSE32509 | GSM831012 - GSM831013 - GSM831014 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Erythrocytic leukemia cells | [CL] K562 | SAP30 | GSE32509 | GSM831018 - GSM831019 | erythrocytic leukemia cells (ATCC CCL-243) from pa... |
| Chronic myeloid leukemia | [CL] K562 | ZNF143 | GSE39263 | GSM959047 | CML in blast crisis |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] HPB-ALL | ZNF143 | GSE39263 | GSM959049 | N/A |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] HPB-ALL | NOTCH1 | GSE39263 | GSM959056 | N/A |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 | RUNX1 | GSE29225 | GSM722704 | AML FAB M2 and t(8;21) |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 | RUNX1/ETO | GSE29225 | GSM722705 | AML FAB M2 and t(8;21) |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 + mismatch siRNA | RUNX1/ETO | GSE29225 | GSM722706 | AML FAB M2 and t(8;21) transfected with mismatch s... |
| Acute myeloid leukemia (AML) | [PC] PB MNC | RUNX1 | GSE29225 | GSM722708 | Peripheral blood mononuclear CD34+ blast cells fro... |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 + mismatch siRNA | POLR2A | GSE29225 | GSM722709 | AML FAB M2 and t(8;21) transfected with mismatch s... |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 + RUNX1/ETO siRNA | POLR2A | GSE29225 | GSM722710 | AML FAB M2 and t(8;21) transfected with RUNX1/ETO ... |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 + mismatch siRNA | RUNX1 | GSE29225 | GSM850823 | AML FAB M2 and t(8;21) transfected with mismatch s... |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 + RUNX1/ETO siRNA | RUNX1 | GSE29225 | GSM850824 | AML FAB M2 and t(8;21) transfected with RUNX1/ETO ... |
| Acute myeloid leukemia (AML) | [PC] Blast cells | RUNX1T1 | GSE29225 | GSM850826 | Human patient B with t(8;21) |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 + RUNX1/ETO siRNA | SPI1 | GSE60131 | GSM1501167 | AML FAB M2 and t(8;21) transfected with RUNX1/ETO ... |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 + scrambled siRNA | SPI1 | GSE60131 | GSM1501166 | AML FAB M2 and t(8;21) transfected with scrambled ... |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 + RUNX1/ETO siRNA | LMO2 | GSE60131 | GSM1501165 | AML FAB M2 and t(8;21) transfected with RUNX1/ETO ... |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 + scrambled siRNA | LMO2 | GSE60131 | GSM1501164 | AML FAB M2 and t(8;21) transfected with scrambled ... |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 + RUNX1/ETO siRNA | CEBPA | GSE60131 | GSM1501163 | AML FAB M2 and t(8;21) transfected with RUNX1/ETO ... |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 + scrambled siRNA | CEBPA | GSE60131 | GSM1501162 | AML FAB M2 and t(8;21) transfected with scrambled ... |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 + RUNX1/ETO siRNA | EP300 | GSE60131 | GSM1466007 | AML FAB M2 and t(8;21) transfected with RUNX1/ETO ... |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 + scrambled siRNA | EP300 | GSE60131 | GSM1466006 | AML FAB M2 and t(8;21) transfected with scrambled ... |
| B-Cells | [CL] Lymphoblastoid | RUNX3 | GSE32465 | GSM1010893 | GM12878 cell from ENCODE project. |
| Erythroid Leukemia | [CL] HEL | STAT5 | E-MTAB-1096 | - - | No drug (DMSO?) |
| B-lymphocytes | [PC] Germinal Center B-Cells | BCL6 | GSE43350 | GSM898060 | N/A |
| B-lymphocytes | [PC] Germinal Center B-Cells | BCOR | GSE43350 | GSM898061 | N/A |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] Jurkat | MED1 / TRAP220 | GSE59657 | GSM1442004 | N/A |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] Jurkat | MYB | GSE59657 | GSM1442005 | N/A |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] Jurkat | MYB | GSE59657 | GSM1442006 | N/A |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] Jurkat | MYB | GSE59657 | GSM1519635 | N/A |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] Jurkat | MYB | GSE59657 | GSM1519639 | N/A |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] Jurkat | MYB | GSE59657 | GSM1519641 | N/A |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] MOLT-3 | MYB | GSE59657 | GSM1519643 | 2der7 and t(7;7) |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] MOLT-3 | TAL1 | GSE59657 | GSM1519646 | 2der7 and t(7;7) |
| B-lymphocytes | [PC] Germinal Center B-Cells | SMRT | GSE43350 | GSM898062 | N/A |
| Pro-B acute lymphoblastic leukemia (B-ALL) | [CL] SEM | RUNX1 | GSE42075 | GSM1032075 | note this cell line is biphenotypic with a small p... |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 | RUNX1 | GSE45748 | GSM1113427 - GSM1113428 | AML FAB M2 and t(8;21); RUNX1 c-terminus |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 | RUNX1T1 / ETO | GSE45748 | GSM1113429 - GSM1113430 | AML FAB M2 and t(8;21) |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 | REPIN1 / AP4 | GSE45748 | GSM1113433 - GSM1113434 | AML FAB M2 and t(8;21) |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 | RUNX1 | GSE45748 | GSM1113437 - GSM1113438 | AML FAB M2 and t(8;21); RUNX1 n-terminus |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] Jurkat E6.1 | TAL1 | GSE29181 | GSM722164 - GSM722165 | N/A |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] Jurkat E6.1 | TCF12 / HEB | GSE29181 | GSM722166 | N/A |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] Jurkat E6.1 | GATA3 | GSE29181 | GSM722168 | N/A |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] Jurkat E6.1 | RUNX1 | GSE29181 | GSM722169 - GSM722170 - GSM722171 | N/A |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] CCRF-CEM | TCF3 / E2A | GSE29181 | GSM837985 | N/A |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] CCRF-CEM | GATA3 | GSE29181 | GSM837986 | N/A |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] CCRF-CEM | TCF12 | GSE29181 | GSM837987 - GSM837988 | N/A |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] CCRF-CEM | LMO2 | GSE29181 | GSM837992 - GSM837993 | N/A |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] CCRF-CEM | RUNX1 | GSE29181 | GSM837994 - GSM837995 | N/A |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] CCRF-CEM | TAL1 | GSE29181 | GSM837996 - GSM837997 | N/A |
| T-cell acute lymphoblastic leukemia (T-ALL) | [PC] CD34+ T-ALL Primagraft 2 | TAL1 | GSE29181 | GSM837998 - GSM837999 | CD34+ cells selected from human T-ALL samples and ... |
| T-cell acute lymphoblastic leukemia (T-ALL) | [PC] CD34+ T-ALL Primagraft 5 | TAL1 | GSE29181 | GSM838000 - GSM838001 | CD34+ cells selected from human T-ALL samples and ... |
| Dendritic | [PC] Monocyte derived dendritic cells | SPI1 | GSE58864 | GSM1421017 - GSM1421019 | MDDC |
| Acute myeloid leukemia (AML) | [CL] NOMO-1 | ZFX | GSE43022 | GSM1057372 | AML FAB M5a and t(9;11) with MLL rearrangement |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] RPMI-8402 | ZFX | GSE43022 | GSM1057374 | N/A |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] Jurkat | GABPa | GSE49091 | GSM1193662 - GSM1193663 | N/A |
| T-cell acute lymphoblastic leukemia (T-ALL) | [CL] Jurkat | ERG | GSE49091 | GSM1193664 - GSM1193665 | N/A |
| Macrophage | [PC] Macrophage | HIF1a | GSE43109 | GSM1056831 - GSM1056832 | stress: Hypoxy 1% O2 4 hours; treatment: none |
| Macrophage | [PC] Macrophage | HIF2a | GSE43109 | GSM1056835 - GSM1056836 | stress: Hypoxy 1% O2 4 hours; treatment: none |
| Macrophage | [PC] Macrophage | HIF1a | GSE43109 | GSM1056839 - GSM1056840 | stress: Hypoxy 1% O2 4 hours; treatment: Interleuk... |
| Macrophage | [PC] Macrophage | HIF2a | GSE43109 | GSM1056843 - GSM1056844 | stress: Hypoxy 1% O2 4 hours; treatment: Interleuk... |
| Burkitt lymphoma | [CL] Raji | CIITA | GSE52941 | GSM1602232 | ChIP antibody supplied by Rockland Immunochemicals |
| Burkitt lymphoma | [CL] Raji | CIITA | GSE52941 | GSM1602235 - GSM1602236 | ChIP antibody supplied by Diagenode |
| Diffuse large B cell lymphoma (DLBCL) ABC-type | [CL] U2932 | PRDM11 | GSE56065 | GSM1354547 | P53 mutation |
| Acute myeloid leukemia (AML) | [CL] TSU-1621-MT | FLI1 | GSE60477 | GSM1480740 | AML FAB M4 and t(16;21) treated with ATRA |
| Acute myeloid leukemia (AML) | [CL] TSU-1621-MT | GATA2 | GSE60477 | GSM1480746 | AML FAB M4 and t(16;21) treated with ATRA |
| Acute myeloid leukemia (AML) | [CL] TSU-1621-MT | LMO2 | GSE60477 | GSM1480745 | AML FAB M4 and t(16;21) treated with ATRA |
| Acute myeloid leukemia (AML) | [CL] TSU-1621-MT | LYL1 | GSE60477 | GSM1480747 | AML FAB M4 and t(16;21) treated with ATRA |
| Acute myeloid leukemia (AML) | [CL] TSU-1621-MT | SPI1 | GSE60477 | GSM1557623 | AML FAB M4 and t(16;21) treated with ATRA |
| Acute myeloid leukemia (AML) | [CL] TSU-1621-MT | RUNX1 | GSE60477 | GSM1480744 | AML FAB M4 and t(16;21) treated with ATRA |
| Acute myeloid leukemia (AML) | [CL] TSU-1621-MT | TAL1 | GSE60477 | GSM1480748 | AML FAB M4 and t(16;21) treated with ATRA |
| Acute myeloid leukemia (AML) | [CL] TSU-1621-MT | RARA | GSE60477 | GSM1480739 | AML FAB M4 and t(16;21) treated with ATRA |
| Acute myeloid leukemia (AML) | [CL] TSU-1621-MT | ERG | GSE60477 | GSM1480735 | AML FAB M4 and t(16;21) treated with ATRA |
| Acute myeloid leukemia (AML) | [CL] TSU-1621-MT | ERG | GSE60477 | GSM1480736 | AML FAB M4 and t(16;21) treated with ATRA |
| Acute myeloid leukemia (AML) | [CL] TSU-1621-MT | FUS | GSE60477 | GSM1480742 | AML FAB M4 and t(16;21) treated with ATRA |
| Acute myeloid leukemia (AML) | [CL] TSU-1621-MT | FUS | GSE60477 | GSM1480743 | AML FAB M4 and t(16;21) treated with ATRA |
| Acute myeloid leukemia (AML) | [CL] TSU-1621-MT | RXRA | GSE60477 | GSM1480741 | This cell line bears translocation t(16;21). No tr... |
| Acute myeloid leukemia (AML) | [CL] TSU-1621-MT | CTDP1 | GSE60477 | GSM1480737 | This cell line bears translocation t(16;21). No tr... |
| Acute myeloid leukemia (AML) | [CL] TSU-1621-MT | CTDP1 | GSE60477 | GSM1480738 | This cell line bears translocation t(16;21). Treat... |
| Plasmacytoid Dendritic Cells | [CL] CAL-1 | CBFA2T3 | GSE43876 | GSM1072710 | N/A |
| Plasmacytoid Dendritic Cells | [CL] CAL-1 | TCF4 | GSE43876 | GSM1072711 | N/A |
| Multiple myeloma | [CL] MM1.S | NR3C1 | GSE63209 | GSM1543894 | MM1.S cells are glucocorticoid-sensitive. Treated ... |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 | JMJD1C | GSE63486 | GSM1550646 | N/A |
| Acute myeloid leukemia (AML) | [CL] Kasumi-1 | LYL1 | GSE63486 | GSM1901542 | N/A |
| Acute myeloid leukemia (AML) | [CL] HL60 | JMJD1C | GSE63486 | GSM1901544 | Please note this cell line originally classified a... |
| Acute myeloid leukemia (AML) | [CL] HL60 | LYL1 | GSE63486 | GSM1901545 | Please note this cell line originally classified a... |
| Acute myeloid leukemia (AML) | [CL] NB4 | JMJD1C | GSE63486 | GSM1901547 | AML FAB M3 with t(15;17) ie Acute Promyelocytic Le... |
| Acute myeloid leukemia (AML) | [CL] NB4 | LYL1 | GSE63486 | GSM1901548 | AML FAB M3 with t(15;17) ie Acute Promyelocytic Le... |
| Acute myeloid leukemia (AML) | [CL] THP-1 | JMJD1C | GSE63486 | GSM1901549 | AML FAB M5 ie Acute Monocytic Leukemia |
| Acute myeloid leukemia (AML) | [CL] THP-1 | LYL1 | GSE63486 | GSM1901550 | AML FAB M5 ie Acute Monocytic Leukemia |
| Haematopoietic stem and progenitor cells | [PC] fetal liver CD34+ HSPCs (F0) | GATA1 | GSE70660 | GSM1816080 | N/A |
| Erythroid Progenitor | [PC] fetal liver ProEs (F5) | TAL1 | GSE70660 | GSM1816083 | N/A |
| Haematopoietic stem and progenitor cells | [PC] fetal liver CD34+ HSPCs (F0) | NFE2 | GSE70660 | GSM1816085 | N/A |
| Erythroid Progenitor | [PC] fetal liver ProEs (F5) | NFE2 | GSE70660 | GSM1816086 | N/A |
| Haematopoietic stem and progenitor cells | [PC] adult bone marrow CD34+ HSPCs (A0) | NFE2 | GSE70660 | GSM1816087 | N/A |
| Haematopoietic stem and progenitor cells | [PC] adult bone marrow CD34+ HSPCs (A0) | IRF2 | GSE70660 | GSM1816088 | N/A |
| Haematopoietic stem and progenitor cells | [PC] fetal liver CD34+ HSPCs (F0) | SPI1 | GSE70660 | GSM1816089 | N/A |
| Haematopoietic stem and progenitor cells | [PC] adult bone marrow CD34+ HSPCs (A0) | SPI1 | GSE70660 | GSM1816090 | N/A |
| Haematopoietic stem and progenitor cells | [PC] fetal liver CD34+ HSPCs (F0) | RUNX1 | GSE70660 | GSM1816091 | N/A |
| Haematopoietic stem and progenitor cells | [PC] adult bone marrow CD34+ HSPCs (A0) | RUNX1 | GSE70660 | GSM1816092 | N/A |
| Multiple myeloma | [CL] MM1.RL | NR3C1 | GSE63209 | GSM1543895 | MM1.RL cells are resistant to glucocorticoid-induc... |
| Multiple myeloma | [CL] MM1.S | BRD4 | GSE43743 | GSM1070124 | N/A |
| Multiple myeloma | [CL] MM1.S | CTCF | GSE43743 | GSM1070125 | N/A |
| Multiple myeloma | [CL] MM1.S | POLR2A | GSE43743 | GSM1070127 | Treated with DMSO for 6 hours, use with Cdk9 inhib... |
| Multiple myeloma | [CL] MM1.S | POLR2A | GSE43743 | GSM1070129 | Treated with 2uM AT7519 drug for 6 hours. |
| Multiple myeloma | [CL] MM1.S | BRD2 | GSE43743 | GSM1247823 - GSM1247824 - GSM1247825 | (rep1, rep2, rep3) |
| Multiple myeloma | [CL] MM1.S | BRD3 | GSE43743 | GSM1247828 | AB367A |
| Multiple myeloma | [CL] MM1.S | BRD3 | GSE43743 | GSM1247829 - GSM1247830 - GSM1247831 | (rep1, rep2, rep3) |
| Multiple myeloma | [CL] MM1.S | CDK8 | GSE43743 | GSM1252090 | N/A |
| Multiple myeloma | [CL] KMS11 | EZH2 | GSE57632 | GSM1385748 - GSM1385749 | Recurrent t(4;14) chromosomal translocation leads ... |
| Multiple myeloma | [CL] KMS11 | EZH2 | GSE57632 | GSM1385750 - GSM1385751 | Recurrent t(4;14) chromosomal translocation leads ... |
| Multiple myeloma | [CL] MM1.S | MED1 | GSE49224 | GSM1195555 | Treated with 5nM BET bromodomain inhibitor JQ1 for... |
| Multiple myeloma | [CL] MM1.S | MED1 | GSE49224 | GSM1195556 | Treated with 50nM BET bromodomain inhibitor JQ1 fo... |
| Multiple myeloma | [CL] MM1.S | MED1 | GSE49224 | GSM1195557 | Treated with 5uM BET bromodomain inhibitor JQ1 for... |
| Multiple myeloma | [CL] MM1.S | CDK9 | GSE49224 | GSM1195558 | Treated with 50nM BET bromodomain inhibitor JQ1 fo... |
| Multiple myeloma | [CL] MM1.S | CDK9 | GSE49224 | GSM1195559 | Treated with 5uM BET bromodomain inhibitor JQ1 for... |
| Multiple myeloma | [CL] MM1.S | IRF4 | GSE49224 | GSM1195560 | WT |
| Multiple myeloma | [CL] MM1.S | BRD4 | GSE49224 | GSM1195561 | Treated with 150nM BET bromodomain inhibitor JQ1 f... |
| Multiple myeloma | [CL] MM1.S | POLR2A | GSE49224 | GSM1195562 | Treated with 5nM BET bromodomain inhibitor JQ1 for... |
| Multiple myeloma | [CL] MM1.S | POLR2A | GSE49224 | GSM1195563 | Treated with 50nM BET bromodomain inhibitor JQ1 fo... |
| Multiple myeloma | [CL] MM1.S | POLR2A | GSE49224 | GSM1195564 | Treated with 150nM BET bromodomain inhibitor JQ1 f... |
| Multiple myeloma | [CL] MM1.S | BRD4 | GSE42355 | GSM1038271 | Treated with 500nM BET bromodomain inhibitor JQ1 f... |
| Multiple myeloma | [CL] MM1.S | BRD4 | GSE42355 | GSM1038272 | Treated with 50nM BET bromodomain inhibitor JQ1 fo... |
| Multiple myeloma | [CL] MM1.S | BRD4 | GSE42355 | GSM1038273 | Treated with 5nM BET bromodomain inhibitor JQ1 for... |
| Multiple myeloma | [CL] MM1.S | BRD4 | GSE42355 | GSM1038274 | Treated with 5uM BET bromodomain inhibitor JQ1 for... |
| Multiple myeloma | [CL] MM1.S | BRD4 | GSE42355 | GSM1038275 | Treated with DMSO for 6 hours. |
| Multiple myeloma | [CL] MM1.S | MED1 | GSE42355 | GSM1038276 | Treated with DMSO for 6 hours. |
| Multiple myeloma | [CL] MM1.S | POLR2A | GSE42355 | GSM1038277 | Treated with 500nM BET bromodomain inhibitor JQ1 f... |
| Multiple myeloma | [CL] MM1.S | POLR2A | GSE42355 | GSM1038278 | Treated with DMSO for 6 hours. |
| Multiple myeloma | [CL] MM1.S | CDK9 | GSE42355 | GSM1085732 | JQ1_500nM |
| Multiple myeloma | [CL] MM1.S | MED1 | GSE42355 | GSM1085733 | JQ1_500nM |
| Multiple myeloma | [CL] MM1.S | CDK9 | GSE42355 | GSM1085735 | Treated with DMSO for 6 hours. |
| Multiple myeloma | [CL] MM1.S | BRD4 | GSE42161 | GSM1033753 | Treated with DMSO for 24 hours. |
| Multiple myeloma | [CL] MM1.S | MYC | GSE42161 | GSM1033754 | Treated with 500nM BET bromodomain inhibitor JQ1 f... |
| Multiple myeloma | [CL] MM1.S | CDK9 | GSE42161 | GSM1033756 | Treated with DMSO for 24 hours. |
| Multiple myeloma | [CL] MM1.S | MED1 | GSE42161 | GSM1033760 - GSM1033761 | Treated with DMSO for 24 hours. |
| Multiple myeloma | [CL] MM1.S | POLR2A | GSE42161 | GSM1033764 | Treated with 500nM BET bromodomain inhibitor JQ1 f... |
| Erythrocytic leukemia cells | [CL] K562 | CTCF | GSE70764 | GSM1817654 | Please note this cell line is erythroleukemic but ... |
| Erythrocytic leukemia cells | [CL] K562 | BORIS | GSE70764 | GSM1817655 | Please note this cell line is erythroleukemic but ... |
| Multiple myeloma | [CL] Delta47 | CTCF | GSE70764 | GSM1817658 | IgD-secreting myeloma cell line. |
| Multiple myeloma | [CL] Delta47 | BORIS | GSE70764 | GSM1817659 | IgD-secreting myeloma cell line. |
| Burkitt lymphoma | [CL] Raji | MYC | GSE30726 | GSM762707 | N/A |
| Burkitt lymphoma | [CL] CA46 | MYC | GSE30726 | GSM762708 | N/A |
| Burkitt lymphoma | [CL] Blue1 | MYC | GSE30726 | GSM762709 | N/A |
| Burkitt lymphoma | [CL] BL41 | MYC | GSE30726 | GSM762710 | N/A |
| Burkitt lymphoma | [CL] Ramos | MYC | GSE30726 | GSM762711 | N/A |
| Burkitt lymphoma | [CL] Raji | POLR2A | GSE79385 | GSM2094192 | N/A |
| Burkitt lymphoma | [CL] Raji | EBNA1 | GSE30709 | GSM761687 | N/A |
| Burkitt lymphoma | [CL] Raji | EBNA1 | GSE73887 | GSM1905007 | N/A |
| Burkitt lymphoma | [CL] Raji | POLR2A | GSE52914 | GSM1277991 - GSM1277992 - GSM1277993 | (rep1, rep2, rep3) |
| Burkitt lymphoma | [CL] Raji | Ser2P POLR2A | GSE52914 | GSM1277994 - GSM1277995 | (rep1, rep2) |
| Burkitt lymphoma | [CL] Raji | TYR1P3D12 | GSE52914 | GSM1278000 - GSM1278001 | (rep1, rep2) |
| Burkitt lymphoma | [CL] Raji | TYR1P8G5 | GSE52914 | GSM1278002 | N/A |
| Burkitt lymphoma | [CL] Raji | Pax5 | GSE44551 | GSM1086293 - GSM1086294 | N/A |
| Burkitt lymphoma | [CL] Namalwa | Pax5 | GSE44551 | GSM1086295 - GSM1086296 | N/A |
| Hodgkin lymphoma | [CL] L428-PAX5 | Pax5 | GSE44551 | GSM1086297 - GSM1086298 | Stably transfected the Hodgkin cell line L428 with... |
| Burkitt lymphoma | [CL] Namalwa | IRF3 | GSE44939 | GSM1094195 | Sendai virus (Cantell strain) |
| Burkitt lymphoma | [CL] Namalwa | MED1 | GSE44939 | GSM1094198 | mock (PBS substituted for Sendai virus inoculum) |
| Burkitt lymphoma | [CL] Namalwa | NELFA | GSE44939 | GSM1094200 | mock (PBS substituted for Sendai virus inoculum) |
| Burkitt lymphoma | [CL] Namalwa | NELFA | GSE44939 | GSM1094201 | Sendai virus (Cantell strain) |
| Burkitt lymphoma | [CL] Namalwa | POLR2A | GSE44939 | GSM1094202 | mock (PBS substituted for Sendai virus inoculum) |
| Burkitt lymphoma | [CL] Namalwa | POLR2A | GSE44939 | GSM1094203 | Sendai virus (Cantell strain) |
| Burkitt lymphoma | [CL] Namalwa | Ser2P POLR2A | GSE44939 | GSM1094204 | mock (PBS substituted for Sendai virus inoculum) |
| Burkitt lymphoma | [CL] Namalwa | Ser2P POLR2A | GSE44939 | GSM1094205 | Sendai virus (Cantell strain) |
| Burkitt lymphoma | [CL] Ramos | NIPBL | GSE62063 | GSM1519151 | WT |
| Burkitt lymphoma | [CL] Ramos | NIPBL | GSE62063 | GSM1519152 | WT |
| Burkitt lymphoma | [CL] Akata | BZLF1 | GSE58245 | GSM1404654 | Surface IgG on Akata cells was cross-linked by app... |
| Burkitt lymphoma | [CL] Akata | BZLF1 | GSE58245 | GSM1404655 | Surface IgG on Akata cells was cross-linked by app... |
| Burkitt lymphoma | [CL] BJAB | CTCF | GSE31485 | GSM782156 | N/A |
| Burkitt lymphoma | [CL] BL41 | CTCF | GSE31485 | GSM782158 | N/A |
